FITC Anti-Influenza A Virus antibody (ab20388)
Key features and details
- FITC Goat polyclonal to Influenza A Virus
- Suitable for: ICC/IF, IHC-P
- Reacts with: Influenza A
- Conjugation: FITC. Ex: 493nm, Em: 528nm
- Isotype: IgG
Overview
-
Product name
FITC Anti-Influenza A Virus antibody
See all Influenza A Virus primary antibodies -
Description
FITC Goat polyclonal to Influenza A Virus -
Host species
Goat -
Conjugation
FITC. Ex: 493nm, Em: 528nm -
Specificity
Purified virions. Specific to H1N1 by IHA. Does not react with HEp-2 cells. May cross-react with Chicken cellular proteins. Does not cross-react with Influenza B, RSV, Para 1-3 or Adenovirus. -
Tested applications
Suitable for: ICC/IF, IHC-Pmore details -
Species reactivity
Reacts with: Influenza A -
Immunogen
Influenza A Strain USSR (H1N1)
-
General notes
Keep in the dark.Covalently coupled with high purity Isomer I of fluorescein isothiocyanate. Care is taken to ensure complete removal of any free fluorescein from the final product.
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
Preservative: 0.1% Sodium azide
Constituents: 0.0268% PBS, 1% BSA -
Concentration information loading...
-
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Isotype control
-
Recombinant Protein
Applications
Our Abpromise guarantee covers the use of ab20388 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ICC/IF | ||
IHC-P |
IHC-P: Use at an assay dependent dilution.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Target
-
Relevance
Influenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza type C infections cause a mild respiratory illness and are not thought to cause epidemics. Influenza A viruses are further categorized into subtypes on the basis of two surface antigens: hemagglutinin (H) and neuraminidase (N). Strains are also described by geographic origin, strain number and year of isolation. -
Cellular localization
Nuclear -
Database links
- Entrez Gene: 956531 Influenza A
- SwissProt: P03452 Influenza A
- SwissProt: P03466 Influenza A
- SwissProt: P18072 Influenza A
Protocols
References (2)
ab20388 has been referenced in 2 publications.
- Jacquet N et al. Hydrophobin fusion of an influenza virus hemagglutinin allows high transient expression in Nicotiana benthamiana, easy purification and immune response with neutralizing activity. PLoS One 9:e115944 (2014). PubMed: 25541987
- Nakayama M et al. Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine. PLoS One 8:e82740 (2013). PubMed: 24376571